TH and depressive symptom measurement: Particularly, immunofluorescent staining analysis demonstrated that LETX-VI pretreatment prevented TH and dopaminergic neurons from the adverse influence of LPS, suggesting that LETX-VI may promote the synthesis and release of dopamine that is implicated in depression and other dopamine-related diseases (33, 34).